THE PEOPLE WE HELP AND OUR LATEST TRANSACTIONS

AIM Brokerships and Clients

Recent Transactions

 

COMPANY

VALUE

ROLE

DATE

Summit Corporation PLC Placing raising £2.64m out of £5m Joint Broker April 2012
ValiRx PLC £900,000 Broker April 2012
Angel Biotechnology Holdings PLC Logo Angel Biotechnology Holdings PLC £1m Broker March 2012
Seren Photonics Ltd £1.1m Broker to the fundraise March 2012
  Sorbic International Plc £714,000 Joint Broker to the Placing February 2012
  MediaZest Plc £160,000 Broker February 2012
Angel Biotechnology Holdings PLC Logo Angel Biotechnology Holdings PLC £1.15m Broker December 2011
TRT Logo Transense Technologies Plc £1.33m Broker December 2011
TRT Logo Transense Technologies Plc Proposed Fundraising Financial Adviser November 2011
Oxford Pharmascience Group Plc £1.13m Financial Adviser & Broker November 2011
Plethora Solutions Holdings Plc £2.052m Lead Broker September 2011
Summit Corporation PLC  
£1.35m Joint Placing Agent
July 2011
Plethora Solutions Holdings Plc £1.255m Joint Broker April 2011
Amur Minerals Corporation £2.5m Broker March 2011
ValiRx PLC £3.3m Broker February 2011
Sareum Holdings PLC  £500,000 Broker February 2011
Angel Biotechnology Holdings PLC Logo Angel Biotechnology Holdings PLC £1.94m Broker January 2011
Sareum Holdings PLC 
£250,000 Broker December 2010
Plethora Solutions Holdings Plc
£800,000 Broker December 2010
ValiRx PLC
£255,000 Broker November 2010
Semco Minerals PLC £1.7m Broker November 2010
Amur Minerals Corporation £2.02m Broker October 2010
Avantages Assistance PLC

€700,000

Broker and Financial Advisor September 2010
Sareum Holdings PLC   £200,000 Broker August 2010

Amur Minerals Corporation £1.24m Broker July 2010
   TRT Logo
Transense Technologies Plc £2m Broker June 2010
Stanelco Logo Stanelco Plc £3m
Placing Agent
May 2010
 Lipoxen Placing Lipoxen PLC £1.2m Placing Agent April 2010
ValiRx PLC  £500,000 Joint Broker April 2010
Plant Impact PLC Logo Equatorial Palm Oil PLC £6.5m and £1.15m follow on Placing Agent to IPO February 2010
Plant Impact PLC Logo Plant Impact PLC  
£2.1m Joint Broker February 2010
 Angel Biotechnology Holdings PLC Logo Angel Biotechnology Holdings PLC £1.425m Broker to Placing February 2010
Summit Corporation PLC  
£5.4m Broker to Placing
December 2009
Sareum Holdings PLC Logo Sareum Holdings PLC  
£500,000 Broker October 2009
Sea Energy Plc Logo Sea Energy Plc  
£7.5m Broker to Placing September 2009
Sareum Holdings PLC Logo Sareum Holdings PLC  
£315,000 Broker September 2009
Plant Impact PLC Logo Plant Impact PLC  
£1.5m Broker to Placing July 2009
Henderson Morley PLC Logo Henderson Morley PLC  
£300,000 Broker January 2009
Henderson Morley PLC Logo Henderson Morley PLC  
£500,000 Broker April 2008
Prometheus Energy Co.  
$25m Broker to Placing August 2007
HML Holdings PLC Logo HML Holdings PLC  
£2m Placing Agent July 2007
Cellexus Biosystems Logo Cellexus Biosystems  
£1m Broker

April 2007

Testimonials

"Hybridan have been a breath of fresh air since they began working with us last year. They've made a real effort to understand our business and seem to have a real grasp of what makes an ambitious small-cap growth Company like Transense tick. Claire and her team have provided consistently valuable counsel in our dealings with the City, and during our successful fund-raising last year, were able to share their wealth of experience on how to present our investment case to potential new investors both clearly and concisely. Being able to concentrate fully on the commercial and operational aspects of running the Transense business, confident in the knowledge that Hybridan are efficiently managing communication with all our stakeholders in the background, is a real pleasure."

Graham Storey, CEO, Transense Technologies plc


"The Team at Hybridan provide a highly professional, yet very personal broking service, where it is clear, right from the start of a conversation, that they have done their homework, they know your business and that your success really matters to them.  Whether it is carefully considered advice, good judgement, an insightful reading of the markets or their remarkable ability to raise money for clients, we at ValiRx have always felt that Hybridan gives us that added value, that extra leg that for a small business makes all the difference.  I am delighted to see their continued impressive growth – a clear sign that others share our view – and I wish them all success in the future"

Dr Satu Vainikka, CEO, ValiRx Plc


"Having been listed for nearly 5 years on Plus SX, One Media Publishing Group PLC has gained a great deal of experience in choosing its professional partners. With a plethora of Auditors, Lawyers, and Corporate Advisers to chose from, we have learned that price should not be the 'driver'. Hybridan in our opinion offers a wealth of 'City' expertise and a deep 'resource' of 'broking' knowledge. We found their practical approach to our exacting requirement to both fit our 'size' and standing as a micro-cap. We have expanded our relationship to include the preparation of a 'research note' which was executed with efficiency and demonstrated a remarkable insight to our business for existing investors and those looking to invest. I have no doubt that our commercial relationship  will see both OMP and Hybridan benefit through each other’s experience in embracing the markets and working them to enhance shareholder value."

Michael Infante, Chairman and CEO, One Media Publishing Group Plc


"We have been working with Hybridan since 2010 and strongly recommend any small cap company seriously consider them as part of their advisory team. Claire Noyce, CEO Hybridan, is one of the most dedicated and committed investment bankers I have had the pleasure to work with. She is building one of the most effective teams in the City to serve the needs of small cap companies. In 2010 we appointed Hybridan as our joint-broker.  Hybridan is committed, hungry and assertive. In fact they have out-performed larger firms hands down.  Hybridan got stuck into a difficult fund raising immediately after appointment.  They have never been phased by our growth plans, in fact they have actively encouraged our pursuit of deals to deliver shareholder value."

Ronald Openshaw, CEO, Plethora Solutions Holdings Plc